This company seems to have been delisted
Reason: Rebranded as Talphera
Last recorded trade on: March 13, 2024
Source: https://www.fiercepharma.com/marketing/acelrx-becomes-talphera-adopting-new-name-reflect-pain-pivot
Reason: Rebranded as Talphera
Last recorded trade on: March 13, 2024
Source: https://www.fiercepharma.com/marketing/acelrx-becomes-talphera-adopting-new-name-reflect-pain-pivot
AcelRx Pharmaceuticals
ACRX
₹73.60
Share price
7.50%
Change (1 day)
44.66%
Change (1 year)
Categories
Operating Margin for AcelRx Pharmaceuticals (ACRX)
Operating Margin as of April 2025 (TTM): 0.00%
According to AcelRx Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 0.00%. At the end of 2021 the company had an Operating Margin of -1,164.05%.
Operating Margin history for AcelRx Pharmaceuticals from 2012 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -1,164.05% | 70.07% |
| 2020 | -684.45% | -69.89% |
| 2019 | -2,273.44% | 41.38% |
| 2018 | -1,608.04% | 236.8% |
| 2017 | -477.45% | 166.99% |
| 2016 | -178.83% | 88.92% |
| 2015 | -94.66% | -83.92% |
| 2014 | -588.73% | 2505.17% |
| 2013 | -22.60% | -98.26% |
| 2012 | -1,298.25% | -28.08% |
| 2011 | -1,805.22% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | -879.80% | N/A | 🇺🇸 USA |
 | 4.99% | N/A | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.